Azzad Asset Management’s ResMed RMD Stock Holding History

Azzad Asset Management’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$1.26M	Buy	5,713 +1,111	+24%	+$242K	0.11%	207
2026 Q2	$897K	Sell	4,602 -4	-0.1%	-$829	0.08%	250
2026 Q1	$1.03M	Buy	4,606 +143	+3%	+$35.6K	0.1%	226
2025 Q4	$1.08M	Buy	4,463 +3,261	+271%	+$834K	0.11%	226
2025 Q3	$329K	Buy	+1,202	New	+$328K	0.03%	304
2021 Q3	–	Sell	-1,035	Closed	-$255K	–	338
2021 Q2	$255K	Hold	1,035	–	–	0.04%	309
2021 Q1	$201K	Hold	1,035	–	–	0.03%	306
2020 Q4	$220K	Buy	+1,035	New	+$206K	0.04%	281
2020 Q1	–	Sell	-2,074	Closed	-$360K	–	337
2019 Q4	$360K	Hold	2,074	–	–	0.04%	326
2019 Q3	$339K	Buy	+2,074	New	+$272K	0.04%	325

Other funds holding RMD

BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM

State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 38.25% 1-Year Est. Return

Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return

Invesco Atlanta, Georgia $1.27T AUM 50.62% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $127B AUM 33.25% 1-Year Est. Return

Azzad Asset Management's RMD Position: Q3 2026 in Review

Azzad Asset Management increased its ResMed (RMD) stake by 24% in Q3 2026, buying an estimated $242K and bringing the position to 5,713 shares worth $1.26M. The position accounts for 0.11% of the portfolio, ranked #207.

Azzad Asset Management first reported a position in RMD in Q3 2019 and has held it in 10 quarters since. 739 funds tracked by Wall St. Rank hold RMD as of Q3 2026.

Azzad Asset Management held 5,713 shares of ResMed worth $1.26M as of Q3 2026.
Azzad Asset Management bought 1,111 ResMed shares in Q3 2026, an estimated $242K.
ResMed made up 0.11% of Azzad Asset Management's portfolio in Q3 2026, its #207 holding.
Azzad Asset Management first reported a position in ResMed in Q3 2019 and has held it in 10 quarters since.
739 funds tracked by Wall St. Rank held ResMed as of Q3 2026.

Based on Azzad Asset Management's 13F filing for Q3 2026, filed 4 Nov 2026.